NDUFS4 and Leigh syndrome: For instance, in the case of Leigh syndrome (LS), one of the most common and severe mitochondrial diseases, pre-clinical studies testing small molecules showed remarkable therapeutic effects in Ndufs4−/− mice [15,16,17,18].